Puma Biotechnology Inc (NYSE: PBYI) has had one of its most volatile weeks in recent memory thanks to weak demand for a secondary offering. falling over 28 percent from its Tuesday high of $54.65
To make things even more interesting for traders, the biotech company is also part of the SEC’s new tick size pilot program, which began at the beginning of the month.
On October 3, 1,200 small-cap stocks began trading in five-cent increments as part of test. Many of the stocks selected to participate in the program are typically thinly-traded, and the SEC is looking to see what type of impact a five-cent tick increment will have on trading volume and market liquidity.
The SEC is hoping that increasing the tick size for these stocks will encourage brokers to make markets in many of these thinly-traded stocks and reduce the volatility and risk in the names.
PreMarket Prep’s Dennis Dick believes over-the-counter trading volumes have a much bigger impact on small cap liquidity than tick size.
“They may need…
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!